Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 72 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

18 trials in Phase 3/4

Results Transparency

0%

0 of 16 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
17(41.5%)
N/A
14(34.1%)
Early Phase 1
4(9.8%)
Phase 2
4(9.8%)
Phase 1
1(2.4%)
Phase 3
1(2.4%)
41Total
Phase 4(17)
N/A(14)
Early Phase 1(4)
Phase 2(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (72)

Showing 20 of 72 trials
NCT07319338Not Yet Recruiting

Objective Vascular Biomarkers as Triage for Depression in Chronic Atrophic Gastritis

Role: lead

NCT06874738Not Yet Recruiting

A Real-world Clinical Study on the Treatment of Menopausal Syndrome With Liuwei Dihuang Pills

Role: lead

NCT03418779Phase 2Active Not Recruiting

Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD

Role: collaborator

NCT05138965Completed

the Method of Cotton Padding Promoting the Rectovaginal Fistula Surgery

Role: lead

NCT05310175Not ApplicableUnknown

Efficacy of Acupuncture at Acupoints Group Around the Base of Skull for Post-Stroke Depression

Role: lead

NCT05586048Unknown

Effectiveness of Yiqi Fumai Lyophilized Injection for Acute Heart Failure

Role: lead

NCT04163835Phase 4Unknown

The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats

Role: lead

NCT05618470Phase 2Unknown

Wumeiwan Jiawei Fang Use in Patients With Blepharospasm

Role: lead

NCT04457531Early Phase 1Unknown

LiuWeiLuoBi Granule for the Treatment of Diabetic Peripheral Neuropathy

Role: lead

NCT04932395Phase 4Unknown

Anshen Buxin Liuwei Pills for the Treatment of Cardiac Neurosis

Role: lead

NCT01677208Phase 4Completed

Danhong Injection in the Treatment of Acute Ischemic Stroke

Role: lead

NCT03174535Completed

Risk Assessment Model for Ischemic Stroke Endpoint Events

Role: lead

NCT05187481Phase 3Unknown

Effect of Jianpi Huatan Decoction on Advanced Colorectal Cancer

Role: collaborator

NCT04658992Unknown

The Registration on the Use of Feilike Heji in Minors

Role: lead

NCT04278963Phase 2Suspended

Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19

Role: lead

NCT04714489Unknown

Public Title:A Study on the Registration of The Use of Feilike HeJi in Adults

Role: lead

NCT04806490Unknown

Standard Scale for Syndrome Differentiation of Yin Deficiency Syndrome

Role: collaborator

NCT03314038Unknown

Syndrome Patterns for Chronic Atrophic Gastritis Malignant Transformation

Role: collaborator

NCT03261934Recruiting

Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation

Role: collaborator

NCT04509817Not ApplicableUnknown

Acupuncture for Oligomenorrhea Due to Polycystic Ovary Syndrome

Role: lead